Segment Information (Tables)

6 Months Ended

Mar. 31, 2022

Segment Reporting [Abstract]

Segment Revenue, Operating (Loss) Income and Depreciation and Amortization

Segment revenue, operating (loss) income, and depreciation and amortization were as follows:

	Three Months Ended						Six Months Ended
	March 31,						March 31,
(In thousands)	2022			2021			2022			2021
Revenue:
Medical Device	$	18,453		$	27,907		$	35,361		$	44,103
In Vitro Diagnostics		7,653			7,088			13,748			13,189
Total revenue	$	26,106		$	34,995		$	49,109		$	57,292
Operating (loss) income:
Medical Device	$	(5,612	)	$	8,564		$	(9,404	)	$	7,971
In Vitro Diagnostics		3,720			3,809			6,875			7,029
Total segment operating (loss) income		(1,892	)		12,373			(2,529	)		15,000
Corporate		(3,008	)		(2,890	)		(5,812	)		(5,424	)
Total operating (loss) income	$	(4,900	)	$	9,483		$	(8,341	)	$	9,576
Depreciation and amortization:
Medical Device	$	2,133		$	1,721		$	4,327		$	3,373
In Vitro Diagnostics		86			88			172			193
Corporate		101			97			197			200
Total depreciation and amortization	$	2,320		$	1,906		$	4,696		$	3,766